These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 35197823

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Disease-Modifying Effects of a Glial-targeted Inducible Nitric Oxide Synthase Inhibitor (1400W) in Mixed-sex Cohorts of a Rat Soman (GD) Model of Epilepsy.
    Vasanthi SS, Rao NS, Samidurai M, Massey N, Meyer C, Gage M, Kharate M, Almanza A, Wachter L, Mafuta C, Trevino L, Carlo AM, Bryant E, Corson BE, Wohlgemuth M, Ostrander M, Wang C, Thippeswamy T.
    Res Sq; 2023 May 08. PubMed ID: 37214912
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam.
    Marrero-Rosado B, de Araujo Furtado M, Schultz CR, Stone M, Kundrick E, Walker K, O'Brien S, Du F, Lumley LA.
    Epilepsia; 2018 Dec 08; 59(12):2206-2218. PubMed ID: 30368799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication.
    Shih TM, McDonough JH.
    Arch Toxicol; 2000 May 08; 74(3):165-72. PubMed ID: 10877003
    [Abstract] [Full Text] [Related]

  • 8. A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.
    Miller SL, Aroniadou-Anderjaska V, Figueiredo TH, Prager EM, Almeida-Suhett CP, Apland JP, Braga MF.
    Toxicol Appl Pharmacol; 2015 Apr 15; 284(2):204-16. PubMed ID: 25689173
    [Abstract] [Full Text] [Related]

  • 9. Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
    Figueiredo TH, Aroniadou-Anderjaska V, Apland JP, Rossetti K, Braga MF.
    Exp Biol Med (Maywood); 2023 Apr 15; 248(7):612-623. PubMed ID: 37300407
    [Abstract] [Full Text] [Related]

  • 10. Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital.
    Jackson C, Ardinger C, Winter KM, McDonough JH, McCarren HS.
    J Pharmacol Toxicol Methods; 2019 Apr 15; 97():1-12. PubMed ID: 30790623
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes.
    RamaRao G, Afley P, Acharya J, Bhattacharya BK.
    BMC Neurosci; 2014 Apr 04; 15():47. PubMed ID: 24708580
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic potential of memantine against soman poisoning in rats.
    Stojiljković MP, Škrbić R, Jokanović M, Bokonjić D, Kilibarda V, Vulović M.
    Toxicology; 2019 Mar 15; 416():62-74. PubMed ID: 30682440
    [Abstract] [Full Text] [Related]

  • 13. Electroencephalographic analysis in soman-exposed 21-day-old rats and the effects of midazolam or LY293558 with caramiphen.
    De Araujo Furtado M, Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Braga MFM.
    Ann N Y Acad Sci; 2020 Nov 15; 1479(1):122-133. PubMed ID: 32237259
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats.
    Lumley LA, Nguyen DA, de Araujo Furtado M, Niquet J, Linz EO, Schultz CR, Stone MF, Wasterlain CG.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):347-357. PubMed ID: 37977809
    [Abstract] [Full Text] [Related]

  • 15. Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam Treatment.
    De Araujo Furtado M, Aroniadou-Anderjaska V, Figueiredo TH, Pidoplichko VI, Apland JP, Rossetti K, Braga MFM.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):432-450. PubMed ID: 37739807
    [Abstract] [Full Text] [Related]

  • 16. [Prevention and treatment of status epilepticus induced by soman].
    Blanchet G, Carpentier P, Lallement G, Sentenac-Roumanou H.
    Ann Pharm Fr; 1994 Jan 17; 52(1):11-24. PubMed ID: 8085742
    [Abstract] [Full Text] [Related]

  • 17. Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman.
    Reddy DS, Zaayman M, Kuruba R, Wu X.
    Neuropharmacology; 2021 Jun 15; 191():108571. PubMed ID: 33878303
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
    Nguyen DA, Stone MF, Schultz CR, de Araujo Furtado M, Niquet J, Wasterlain CG, Lumley LA.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):376-385. PubMed ID: 37770198
    [Abstract] [Full Text] [Related]

  • 19. Age-Related Susceptibility to Epileptogenesis and Neuronal Loss in Male Fischer Rats Exposed to Soman and Treated With Medical Countermeasures.
    Marrero-Rosado B, Rossetti F, Rice MW, Moffett MC, Lee RB, Stone MF, Lumley LA.
    Toxicol Sci; 2018 Jul 01; 164(1):142-152. PubMed ID: 29596688
    [Abstract] [Full Text] [Related]

  • 20. Sex-based structural and functional MRI outcomes in the rat brain after soman (GD) exposure-induced status epilepticus.
    Gage M, Vasanthi SS, Meyer CM, Rao NS, Thedens DR, Kannurpatti SS, Thippeswamy T.
    Epilepsia Open; 2023 Jun 01; 8(2):399-410. PubMed ID: 36718979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.